Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.EMD Millipore, the Life Science division of German Merck KgaA, has taken over Amnis, which develops, manufactures and markets instrumentation for high speed cell imaging for research and diagnostic markets.
Subscribe to our email newsletter
EMD Millipore offers a range of performance products, services and business relationships that enable customers’ success in research, development and production of biotech and pharmaceutical drug therapies.
With this acquisition, Amnis will expand its growth potential via EMD Millipore’s global footprint, reagent expertise, and R&D resources.
Further, the acquisition will also complement EMD Millipore’s Guava flow cytometry product range.
Amnis CEO David Basiji said the combination of Amnis with EMD Millipore will accelerate development of novel applications in imaging flow cytometry, enhance their customer support, and accelerate product development.